Announcements & Circulars-Alphamab Oncology

English 中文简体中文繁体

English 中文简体中文繁体

Investors

Information Disclosure

Listing Documents

Financial Reports

Announcements & Circulars

Company Presentation

Corporate Governance

Stock Information

Corporate Communications

Email Subscription

Announcements & Circulars

The announcement begins in December 2019

WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES 2024-10-29
Next Day Disclosure Return 2024-10-23
(1) GRANT OF SHARE OPTIONS UNDER THE POST-IPO SHARE OPTION SCHEME; AND (2) GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME 2024-10-23
(1) APPOINTMENT OF NON-EXECUTIVE DIRECTOR AND A MEMBER OF STRATEGY COMMITTEE; (2) CHANGE OF JOINT COMPANY SECRETARY AND AUTHORIZED REPRESENTATIVE; AND (3) WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES 2024-10-22
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024 2024-10-07
INSIDE INFORMATION ANNOUNCEMENT - COLLABORATION WITH CSPC IN RELATION TO THE DEVELOPMENT AND COMMERCIALIZATION OF JSKN003 IN MAINLAND CHINA 2024-09-29
VOLUNTARY ANNOUNCEMENT – RESEARCH UPDATES ON A PHASE I CLINICAL STUDY AND A PHASE I/II CLINICAL STUDY OF JSKN003 FOR PRESENTATION AT ESMO CONGRESS 2024 2024-09-15
INSIDE INFORMATION ANNOUNCEMENT – UPDATES IN RELATION TO A PHASE III CLINICAL TRIAL OF KN046 FOR THE TREATMENT OF ADVANCED SQ NSCLC 2024-09-08
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024 2024-09-05
Next Day Disclosure Return 2024-09-03